ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: BPTES treatment of low-oxygen CML cell cultures yielded results similar to those of the inhibitors of glucose metabolism, indicating that the conversion of glutamine to glutamate controls glucose consumption and the consequent BCR/Abl suppression.